LS Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-2,574
| Closed | -$1.22M | – | 605 |
|
2021
Q1 | $1.22M | Sell |
2,574
-285
| -10% | -$135K | 0.07% | 215 |
|
2020
Q4 | $1.38M | Buy |
2,859
+428
| +18% | +$207K | 0.07% | 232 |
|
2020
Q3 | $1.36M | Buy |
2,431
+124
| +5% | +$69.4K | 0.08% | 213 |
|
2020
Q2 | $1.44M | Buy |
2,307
+97
| +4% | +$60.5K | 0.09% | 196 |
|
2020
Q1 | $1.08M | Sell |
2,210
-330
| -13% | -$161K | 0.08% | 228 |
|
2019
Q4 | $954K | Sell |
2,540
-50
| -2% | -$18.8K | 0.05% | 309 |
|
2019
Q3 | $718K | Buy |
2,590
+28
| +1% | +$7.76K | 0.04% | 350 |
|
2019
Q2 | $802K | Buy |
2,562
+140
| +6% | +$43.8K | 0.05% | 329 |
|
2019
Q1 | $995K | Buy |
2,422
+74
| +3% | +$30.4K | 0.06% | 273 |
|
2018
Q4 | $877K | Sell |
2,348
-77
| -3% | -$28.8K | 0.06% | 277 |
|
2018
Q3 | $980K | Sell |
2,425
-107
| -4% | -$43.2K | 0.06% | 292 |
|
2018
Q2 | $874K | Buy |
2,532
+66
| +3% | +$22.8K | 0.05% | 316 |
|
2018
Q1 | $849K | Buy |
2,466
+1
| +0% | +$344 | 0.05% | 320 |
|
2017
Q4 | $927K | Buy |
2,465
+358
| +17% | +$135K | 0.05% | 298 |
|
2017
Q3 | $942K | Buy |
2,107
+114
| +6% | +$51K | 0.06% | 289 |
|
2017
Q2 | $979K | Sell |
1,993
-70
| -3% | -$34.4K | 0.06% | 275 |
|
2017
Q1 | $799K | Buy |
2,063
+228
| +12% | +$88.3K | 0.05% | 302 |
|
2016
Q4 | $674K | Buy |
1,835
+45
| +3% | +$16.5K | 0.05% | 320 |
|
2016
Q3 | $720K | Sell |
1,790
-239
| -12% | -$96.1K | 0.05% | 283 |
|
2016
Q2 | $709K | Buy |
2,029
+108
| +6% | +$37.7K | 0.05% | 310 |
|
2016
Q1 | $692K | Buy |
1,921
+135
| +8% | +$48.6K | 0.05% | 297 |
|
2015
Q4 | $970K | Buy |
1,786
+91
| +5% | +$49.4K | 0.08% | 235 |
|
2015
Q3 | $788K | Sell |
1,695
-12
| -0.7% | -$5.58K | 0.06% | 252 |
|
2015
Q2 | $871K | Sell |
1,707
-156
| -8% | -$79.6K | 0.06% | 244 |
|
2015
Q1 | $841K | Sell |
1,863
-28
| -1% | -$12.6K | 0.06% | 253 |
|
2014
Q4 | $776K | Sell |
1,891
-148
| -7% | -$60.7K | 0.06% | 241 |
|
2014
Q3 | $735K | Sell |
2,039
-159
| -7% | -$57.3K | 0.06% | 232 |
|
2014
Q2 | $621K | Buy |
2,198
+36
| +2% | +$10.2K | 0.05% | 255 |
|
2014
Q1 | $649K | Buy |
2,162
+1,172
| +118% | +$352K | 0.05% | 245 |
|
2013
Q4 | $272K | Buy |
990
+627
| +173% | +$172K | 0.02% | 396 |
|
2013
Q3 | $114K | Buy |
363
+98
| +37% | +$30.8K | 0.01% | 279 |
|
2013
Q2 | $60K | Buy |
+265
| New | +$60K | 0.01% | 295 |
|